Diagnostics/November 7, 2025

Pregnancy Quad Marker Screen Test: Purpose, Test Details & Results

Learn the purpose of the pregnancy quad marker screen test, how it works, what results mean, and key follow-up steps for expecting parents.

Researched byConsensus— the AI search engine for science

Table of Contents

Purpose of Pregnancy Quad Marker Screen Test

Expecting a baby brings excitement—and a desire for reassurance about your child’s health. The Pregnancy Quad Marker Screen Test is a valuable tool that helps parents and healthcare providers assess the risk of certain chromosomal conditions and birth defects during pregnancy. This non-invasive blood test looks at four specific substances in the mother's blood to detect potential genetic abnormalities and, increasingly, risks for certain pregnancy complications. Let’s explore why this test is recommended and what it aims to uncover.

Marker Purpose Detection Focus Source(s)
AFP Protein from fetal liver Neural tube defects, Down syndrome 1 4 7
hCG Placental hormone Down syndrome, pregnancy monitoring 1 4 5 7
uE3 Estrogen produced by fetus/placenta Down syndrome, genetic disorders 1 2 4 7
Inhibin A Placental hormone Down syndrome, preeclampsia risks 1 4 7
Table 1: Quad Marker Test Components and Purposes

What the Quad Marker Screen Test Is Designed For

The quad marker screen is a second-trimester maternal blood test that measures four substances: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A. Its primary purpose is to estimate the risk of fetal chromosomal abnormalities, particularly Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18), as well as neural tube defects like spina bifida 1 4 5 7.

Why the Test Is Important

This test is especially valuable for:

  • Early risk detection: It helps identify pregnancies at higher risk for certain genetic conditions before birth, allowing for informed choices and early interventions 1 4 5.
  • Non-invasive screening: It requires only a simple blood draw, posing no risk to the fetus 4.
  • Guiding further testing: Abnormal results don’t diagnose a condition but signal when more precise diagnostic tests (like amniocentesis) may be appropriate 1 2.

Expanding the Purpose: Predicting Pregnancy Complications

Beyond genetic conditions, abnormal levels of these markers can hint at increased risks for obstetric complications such as:

  • Preterm birth
  • Preeclampsia (high blood pressure in pregnancy)
  • Intrauterine growth restriction (IUGR)
  • Fetal loss

While the test is not specifically designed to predict these outcomes, research shows that certain marker combinations can serve as early warning signs, prompting closer monitoring 1 2 4 6 8.

Pregnancy Quad Marker Screen Test Details

Understanding what happens during the quad marker screen can help you feel more comfortable and prepared. This section walks you through the process, what’s being measured, and how results are interpreted.

Detail Description Timing/Process Source(s)
Timing 15–22 weeks gestation (best: 16–18 weeks) Second trimester 1 4 5 7
Sample Maternal blood draw Outpatient/clinic visit 1 4
Markers Measured AFP, hCG, uE3, Inhibin A Serum analysis 1 4 7
Interpretation Results expressed as MoM (Multiples of the Median) Compared to population norms 1 5 7
Table 2: Quad Marker Screen Test Details

How the Quad Marker Screen Test Is Performed

  • Timing: The test is typically performed between the 15th and 22nd week of pregnancy, with optimal accuracy around weeks 16–18 1 4 5 7.
  • Procedure: A small blood sample is taken from the mother’s arm during a routine prenatal visit 1 4.
  • Laboratory Analysis: The sample is analyzed for four markers:
    • Alpha-fetoprotein (AFP): Produced by the fetus’s liver.
    • Human chorionic gonadotropin (hCG): A hormone from the placenta.
    • Unconjugated estriol (uE3): An estrogen made by the fetus and placenta.
    • Inhibin A: A hormone from the placenta 1 4 7.

Understanding MoM: Multiples of the Median

To interpret results, each marker’s level is converted into a "Multiple of the Median" (MoM). This standardizes results by comparing them to average values for the same stage of pregnancy 5 7. Adjustments are made for maternal age, weight, ethnicity, and diabetes status to improve accuracy 5 7.

Risk Calculation

Results are fed into risk models—sometimes tailored for specific populations, like Korean women—to estimate the likelihood of certain conditions 5. The test does not diagnose; it stratifies risk:

  • Low-risk: No further action needed.
  • High-risk: Additional diagnostic testing, such as detailed ultrasound or amniocentesis, may be offered 1 2 5 7.

Test Limitations and Considerations

  • False Positives/Negatives: The quad screen is a screening, not definitive, test. Its sensitivity for Down syndrome is about 80% at a 5% false-positive rate 5 7.
  • Special Populations: Interpretation can be challenging in women with multiple pregnancies, kidney disease, or certain ethnic backgrounds 2 3 5.
  • Stress and Anxiety: False positives can cause unnecessary anxiety and lead to further, sometimes invasive, testing 2.

Pregnancy Quad Marker Screen Test Results & Follow-Up

Receiving your quad marker screen results can be nerve-wracking, but understanding what they mean—and what comes next—helps you make informed decisions for your pregnancy journey.

Result Type Implications Possible Next Steps Source(s)
Normal Low risk for screened conditions Routine prenatal care 1 2 4 5
High Risk Increased risk for aneuploidy or birth defect Offer of diagnostic testing 1 2 4 5
Abnormal Markers Possible risk for pregnancy complication Enhanced monitoring, consultations 1 2 4 6 8
Table 3: Quad Marker Screen Results and Follow-Up

Interpreting the Results

  • Normal Result: Indicates a low chance of chromosomal abnormalities or neural tube defects. Routine prenatal care continues 1 2 5.
  • High-Risk Result: Does not mean the baby definitely has a condition, but that the risk is higher than average. About 80% of Down syndrome cases are detected, but false positives do occur 5 7.
  • Abnormal Marker Levels: Even if not flagged for genetic risk, unusual levels of one or more markers may signal increased chances of complications like preeclampsia, fetal growth restriction, or preterm birth 1 2 4 6 8.

Next Steps After Abnormal Results

  • Diagnostic Testing: Based on the risk estimate, your provider may recommend:
    • Amniocentesis for chromosomal analysis
    • Detailed ultrasound to look for structural anomalies 1 2 5
  • Genetic Counseling: You may be referred to discuss results, implications, and options in detail 2.
  • Enhanced Pregnancy Monitoring: If markers suggest risk for complications (like growth restriction or preeclampsia), you may receive:
    • More frequent prenatal visits
    • Additional ultrasounds for fetal growth and amniotic fluid
    • Fetal monitoring (biophysical profile, Doppler studies)
    • Education on warning signs of complications 1 2 4 6 8

Clinical Management Recommendations

  • Individualized Follow-Up: Management should be tailored to the specific abnormal marker(s) found and overall risk profile 2.
  • No Specific Universal Protocol: While guidelines recommend closer surveillance, there is no one-size-fits-all protocol for managing abnormal quad screen results. Consultation with an obstetrician is essential 2.
  • Current Limitations: The test is not used as a population-wide screen for complications like preeclampsia or stillbirth outside research settings, due to limited sensitivity and high false-positive rates 2.

Psychological and Social Considerations

  • Emotional Impact: False positives can cause stress. Supportive counseling is key 2.
  • Value of Informed Decision-Making: The test empowers families to make choices about diagnostic testing and pregnancy management 1 2 5.

Conclusion

The Pregnancy Quad Marker Screen Test is a vital part of modern prenatal care, offering insights not only into genetic risks but also into potential pregnancy complications. Here’s what to remember:

  • Assesses risk for Down syndrome, Edwards syndrome, and neural tube defects through four key blood markers (AFP, hCG, uE3, inhibin A) 1 4 5 7.
  • Performed in the second trimester, it’s a safe, non-invasive screen that informs, but does not diagnose 1 4 7.
  • Results are expressed as risk estimates; abnormal results may prompt further diagnostic testing and enhanced monitoring 1 2 4 5.
  • Abnormal marker levels can signal higher risk for pregnancy complications, warranting individual follow-up and surveillance 1 2 4 6 8.
  • While not perfect, the test empowers families with knowledge and options during pregnancy.

Always discuss your results and next steps with your healthcare provider to ensure the best care for you and your baby.

Sources